Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
about
Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtypeMonoclonal antibody-based therapies for microbial diseasesAntibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination StrategiesHuman erythrocytes selectively bind and enrich infectious HIV-1 virions.4E10-resistant HIV-1 isolated from four subjects with rare membrane-proximal external region polymorphismsRole of Fc in antibody-mediated protection from ricin toxinWhich Antibody Functions are Important for an HIV Vaccine?Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.Fc receptor-mediated antiviral antibodies.Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies.Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting.Neutralizing antibodies inhibit HIV-1 infection of plasmacytoid dendritic cells by an FcγRIIa independent mechanism and do not diminish cytokines production.FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.Detection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system.HIV-1-specific antibody responses during acute and chronic HIV-1 infectionMultiplexing seven miRNA-Based shRNAs to suppress HIV replicationTransmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.A mouse model for HIV-1 entryStrategies for eliciting HIV-1 inhibitory antibodiesDistribution of FcγR gene polymorphisms among two sympatric populations in Mali: differing allele frequencies, associations with malariometric indices and implications for genetic susceptibility to malariaAntibody-DEPENDENT, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis.Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccineesThe role of Fc receptors in HIV prevention and therapy.Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesNeutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challengeAmino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization Sensitivity.Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region.Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection.FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications.Enhancing immunogenicity and cross-reactivity of HIV-1 antigens by in vivo targeting to dendritic cells.A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV.Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques.HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes.Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status.Non-Neutralizing Antibodies Directed against HIV and Their Functions.
P2860
Q27490436-472ACA52-7800-4837-95E1-4869D0B96902Q27490830-58BC29DD-9870-406C-B7DE-FEA8550BE5EFQ30408097-E28A8BE7-0BA9-441B-9436-855547045000Q33518534-069DEB46-5F3D-4688-98A2-039C188E1390Q33547451-A30EC0C1-048B-4A9F-9BE9-57C5A9A0DD9EQ33736516-C75AFC2C-598A-45D6-A2EE-FDE5694CAFE7Q33772637-97A5023E-2C96-43E6-B71B-2F6E1E9EC208Q33827798-A9C2E94D-71B1-40BA-B47B-CB9462656330Q33899181-51037505-98EF-4A7E-BC11-C3020AB7937CQ34006748-9E47505E-BED1-49A2-A187-56B485D8B3E6Q34042758-ABDC64E8-D356-4E9C-BFCF-2F5D773F033DQ34055377-1C5CE88F-B098-4E26-8F0B-E964E7AC96BBQ34117524-886FF5E1-4959-472B-AFC1-35B6B36131D9Q35060140-F1F29122-183D-4917-946D-251C90359A61Q35096836-15679343-BB9E-40CF-957C-F09EBB02B546Q35653244-1376C42F-9DF1-4811-A086-375D942A7EB1Q35842299-CDE5E934-8B01-44D0-BF29-C067ABAED9F7Q36300767-A9857D40-0BE5-41F2-81DE-7372CA3F4DC2Q36452155-634C9821-3456-4DE4-A7C5-E89947774346Q36476336-983D0933-77B6-482C-A3E6-97AFDEE9E127Q36760004-04B78131-A94F-47D0-A629-FFBF4C0F5526Q36978671-A66728A9-5D0C-4ED6-96F5-858BEBB66371Q37113972-29CFDEB7-FA9D-4036-9AE6-E12BACEE586CQ37221575-DC4E33CE-FB22-4E9E-9289-C398377571A0Q37252676-F6E2FF22-DB26-4244-A435-62FC7CC30A73Q37363517-7916A3C2-F083-41E8-92BA-A456D6645EF6Q37410792-6D614A55-A9DB-4F39-86C8-42320FDFE9BAQ37510242-C6F9537A-933D-44AC-84DA-52960DBE282CQ37736263-6401F252-765C-4F22-A163-79A600953851Q38059499-09349A91-8D46-45C9-93F1-FDB8FBEAA1E1Q38631835-F991A3B4-C7B7-47B0-B109-399E49E852CAQ38688524-ABD37940-5AF2-4033-A299-326AE9D5E2A4Q39189458-22C2C227-C11E-465C-AA88-F1985E46D706Q39265150-63EE1991-08F3-4FDE-9672-2EA22F9F7D1FQ39402539-481FDD7E-4417-48B4-A98B-1021F80BD0E6Q40120996-97BD493D-71A1-4B6C-9078-E349EB081004Q47139556-327BE3F4-824A-4DFD-8623-D62058DF2404
P2860
Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Utilization of immunoglobulin ...... ximal external region of gp41.
@en
Utilization of immunoglobulin ...... ximal external region of gp41.
@nl
type
label
Utilization of immunoglobulin ...... ximal external region of gp41.
@en
Utilization of immunoglobulin ...... ximal external region of gp41.
@nl
prefLabel
Utilization of immunoglobulin ...... ximal external region of gp41.
@en
Utilization of immunoglobulin ...... ximal external region of gp41.
@nl
P2093
P2860
P4510
P356
P1433
P1476
Utilization of immunoglobulin ...... ximal external region of gp41.
@en
P2093
Christopher A Todd
Lautaro G Perez
Matthew R Costa
P2860
P304
P356
10.1128/JVI.00656-09
P407
P577
2009-05-20T00:00:00Z